This page is being served from the Urological Sciences Research Foundation web repository, and was originally posted between 1996-2008. In January 2009 USRF’s founder, Dr. Leonard S. Marks and his staff joined UCLA’s Department of Urology where they are continuing their research. Click for more information.
|
Abstracted from CNN and JAMA Websites June 1, 1999 Original CNN Story by Steve Salvatore Study Debunks
Moreover, the King study showed that use of the supplement was associated with significant lowering of high density lipoproteins (so-called "good" cholesterol) in serum and also with increased levels of female hormones estrone and estradiol. Both changes may be related to atherogenesis, the development of lesions in arterial walls which can cause heart attack and stroke. In an accompanying editorial, C.E. Yesalis of Pennsylvania State University wrote that while not illegal, androstenedione is on the banned drug lists of the International Olympic Committee, the National Football League, and the National Collegiate Athletic Association. Yesalis concluded that the King study "contributes to the evidence suggesting that the government should carefully consider intervening and remove androstenedione and its derivatives from the market." |
![]()